Explore the Central Nervous System Therapeutics Market outlook from 2024 to 2033 with comprehensive insights into market drivers including increasing neurological disorder prevalence, aging population demographics, R&D advancements in drug discovery, personalized medicine trends, segmentation by therapeutic class and indication, regional dynamics across North America, Europe, and Asia-Pacific, competitive landscape developments, technological breakthroughs in drug delivery and genomics, regulatory environments, adoption patterns, market challenges, and future growth opportunities shaping neurotherapeutic innovation.
